Annual International Brain Tumor Symposium | Rutgers Cancer Link to Full Transcript: How can lung cancer patients access optimal care? Expert Dr. Christian Rolfo from Phase I/II trial of EP0031, a next generation selective RET inhibitor
Dr. Nagashree Seetharamu, lung cancer care expert from Northwell Health, reviews takeaways from the Pooled Analysis IASLC | International Association for the Study of Lung Cancer RET fusions occur in various cancers, and resistance to selpercatinib and pralsetinib, current first generation selective RET
This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Dr. Heather Wakelee invites you to the 23rd Annual International Lung Cancer Conference: July 28-30
2020 TTF EGFR Breakout PIOTROWSKA Part 1 - Current Options Upon Acquired Resistance to Osimertinib How Can I Get the Best Lung Cancer Care? How Can Specific Biomarkers Impact Lung Cancer Progression?
Upcoming CME Events & Activities | Managed Healthcare Executive Why the IASLC World Conference on Lung Cancer (WCLC) is Unique
ICAHO20 - ASCO Direct™ Highlights - Dr. Jack West - Non-Small Cell Lung Cancer Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer Cancer Survivors Find Information, Encouragement at Houston Conference
Role of Molecular Biology, Evolving Immunotherapy Addressed in This Symposium on the subject of "Non-Small Cell Lung Cancer: Is It Now Multiple Diseases?" was presented at the 13th Annual
Cancer patients face many challenges - but there is also a lot of good news. That was the message in Houston, Texas recently, Discussing Lung ESMO 2022 Highlights - Practice changing studies with Dr. Joshua Reuss, Assistant Professor - Department of The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and
IASLC Webinar: World Conference on Lung Cancer 2020 Highlights 2023 Oncology Nursing Society Metro Denver Chapter Conference - Lung Cancer Update
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses end-of-life decisions faced by a clinical team. IASLC 18th World Conference on Lung Cancer (WCLC 2017) Promo Wistuba, MD. In a presentation at the 23rd Annual International Lung Cancer Congress ®, Wistuba examined a pathologist's approach to
Lung cancer at ASCO 2023: ADAURA and ADCs Lung Cancer | Poster abstracts of the 23rd Annual British Thoracic
David Carbone, MD, PhD, director, James Thoracic Center, Ohio State University Comprehensive Cancer Center, discusses two 25th Annual International Congress on the Future of Breast Cancer Treatment for Patients with EGFR+ NSCLC - Leading Developments & Current Questions in Lung Cancer
"Bridging the Gap": How the National Lung Cancer Audit aims to tackle health inequalities The 1st Annual International Brain Tumor Symposium is supported in part by the New Jersey Pediatric Hematology Oncology Research Center of Excellence (NJ PHORCE) Pathology Expert Unpacks the Future Role MPR and pCR in
Dr. Carbone Discusses Immunotherapy Studies in Lung Cancer Lung ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Joshua Reuss
Dana-Farber Cancer Institute's Dr. Christopher Lathan and Dana-Farber/Harvard Cancer Center's Karen Burns White hosted the Dr Christine Lovly Why Patient Interaction is so important Dr. Christine Lovly on why it is important to get lung cancer researchers together with lung cancer patients to discuss new
Top 4 Highlights from World Conference on Lung Cancer Martin Wermke, MD, University Hospital Carl Gustav Carus, Dresden, Germany, presents his highlights in lung cancer at the
ISPOR 23rd Annual International Meeting. Don't Miss the Latest Insights from Syneos Health. Symposium. Monday, 12: Treatment for Patients with Advanced NSCLC - Leading Developments & Current Questions in Lung Cancer
Dr. Gandara on Practice-Changing Studies in Lung Cancer Ferdinandos Skoulidis, M.D, Ph.D. discusses Current and Emerging Strategies to Tackle KRAS-Mutant NSCLC at KRAS Kickers Thank you for making breakthroughs happen. See how far we've come this year. Together we are beating cancer. Find out more:
Join Dr. Gandara and other renowned experts in lung cancer on July 28 - 30, 2022 for the 23rd Annual International Lung Cancer Christian Rolfo, MD, PhD, MBA, The Tisch Cancer Institute at Mount Sinai, New York, NY, discusses the role of liquid biopsies in Non-Small Cell Lung Cancer: Is It Now Multiple Diseases?
ASCO Daily News 2023 Plenary Update - LBA3: ADAURA As lung cancer screening is a relatively new area, particularly to non-healthcare professionals, understanding of the procedure
Tumor Treating Fields for Lung Cancer - Leading Developments & Current Questions in Lung Cancer Alive and Kicking: Current and Emerging Strategies to Tackle KRAS-Mutant NSCLC
Reserve your spot today: Observing lung cancer progression with liquid biopsies
Genitourinary Cancer (1); Gynecologic Cancer (1); Hematologic Cancer Annual Hematology Meeting: Preceding the 67th ASH Annual Meeting and Roy S. Herbst, MD, PhD, invites you to the 23rd Annual International Lung Cancer Congress®
Friends of Cancer Research Annual Meeting 2023 0:00 - Stream Starts 04:40 - Meeting Begins 07:05 - Opening Keynote Adjuvant Immunotherapy: Questions/Concerns - Leading Developments & Current Questions in Lung Cancer
ISPOR 23rd Annual International Meeting Eric Singhi, MD, a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center, discusses the significance
Cancer Therapies for Ultra-Rare Indications: Presentation from AACR Annual Meeting, April 11, 2022 Jorge Nieva, MD, an associate professor of clinical medicine at the Keck School of Medicine of the University of Southern
David R. Gandara, MD, director, Thoracic Oncology Program, professor, senior advisor to director, UC Davis Comprehensive In-Person & Hybrid Events - PER This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from and interact
Lung Cancer Living Room - Personalized Cancer Care Circa 2019 w/ Dr. Gandara - 10/15/19 - Full 2-hr Friends of Cancer Research Annual Meeting 2023
Dr. David Carbone, of The Ohio State University James Cancer Center, discusses EGFR+ Lung Cancer: What is EGFR? Join Drs Roy S. Herbst, David R. Gandara, and Heather A. Wakelee at the 23rd Annual International Lung Cancer Congress® in
Beth Zigmund, MD, UVM Associate Professor of Radiology "This educational video is content from the UVM Cancer Center's 23rd Cocktail with science - The best of the year in lung cancer Day 2
Providence KATU Family Matters 11/20/20 AMNW: Lung Cancer Screening – Dr. Sanborn Dr. David R. Gandara, MD invites oncologists to attend the 22nd Annual International Lung Cancer Congress® to engage with
In this session, Dr Tejas Patil from University of Colorado provides lung cancer updates. Lung cancer treatment is rapidly evolving. The special edition of the Conference "The best of the year in lung cancer " will provide
Annual Supporter Update 22/23 | Cancer Research UK Roy S. Herbst, MD, PhD, invites you to the 23rd Annual International Lung Cancer Congress® July 28 - July 30, 2022. Join PER® Before the IASLC 19th World Conference on Lung Cancer (#WCLC2018) begins, hear from the IASLC's CEO, Dr. Fred R. Hirsch,
Join Dr. Wakelee and other experts during the 23rd Annual International Lung Cancer Congress® on July 28 - 30. Learn more at: At the upcoming 23rd Annual International Lung Cancer Congress®, Solange Peters, MD, PhD will be giving two presentation around relevant The 8th Annual Cancer Disparities Symposium - April 23, 2021
Click here to claim CME/NCPD/CPE credit for this activity: An estimated 236740 new cases of Dr Nieva on the Rationale for Comparing ALK Inhibitors in ALK+ NSCLC
Dr. Heather Wakelee shares her experience from the annual International Lung Cancer Congress® Poster abstracts of the 23rd Annual British Thoracic Oncology Group Conference 2025. 3-5 March 2025 • ICC Belfast • Publication of this Abstract Book is
May 12, 2014 - The Cancer Genome Atlas 3rd Annual Scientific Symposium More: Opening - Matthew Meyerson & Marco Marra
Dr. Socinski on why you should attend Winter Lung Cancer Conference Josephine Louella Feliciano, MD, assistant professor of oncology, Johns Hopkins Medicine, discusses ROS1-targeted therapy in
Link to Full Transcript: Lung cancer progression can be aided by monitoring of biomarkers, but what do they Pooled Analysis Chemo+IO vs. IO in PDL1 High Cohort | Nagashree Seetharamu, MD | ASCO22 Lung Updates 23rd Annual International Congress on the Future of Breast Cancer
Dr. Singhi on the Significance of the IASLC 2024 World Conference on Lung Cancer Neal Navani, MA, MRCP, MSc, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses a recent An information film to promote informed decision-making for a lung cancer screening
Dr. David R. Gandara, MD Summarizes the The 22nd Annual International Lung Cancer Congress® For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Dr. Jack West from the City of Hope discusses ASCO Updates in Non-Small Cell Lung Cancer at ICAHO20 - an officially licensed
Dr. David Gandara invites you to the 23rd Annual International Lung Cancer Congress® Hear why you should join us this year for the IASLC 18th World Conference on Lung Cancer in Yokohama, Japan.
Jennifer C. King, PhD, Director of Science and Research, shares the top key takeaways from the 19th Annual World Conference Giving a voice to lung cancer
Heather A. Wakelee, MD, invites you to the 23rd Annual International Lung Cancer Congress® July 28 - July 30, 2022. Join PER® Lung Cancer Conference®. In 23rd Annual Winter Lung Cancer Conference®. January 23-25, 2026 · Register now! 27th Annual International Lung Cancer Congress®.
Dr David Carbone on EGFR+ Lung Cancer Listen to the Conference Chairs Discuss Highlights from WCLC 2020. In this live webinar Dr. Yi-long Wu, Dr. Daniel Tan and Dr.
Marta Kauffman, LCFA Board Member and Writer and Exec Producer of Friends and Grace and Frankie, interviews some of the We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient
Dr. David Gandara - University Of California Davis. Dr. Feliciano on ROS1-Targeted Therapy in NSCLC Facing end-of-life decisions as a clinical team
LUNG CANCER SCREENING: A NEW ERA FOR PATIENTS AT RISK An interview with Dr. Roy Herbst from the Yale School of Medicine on the ADAURA study for the 2023 ASCO Annual Meeting. 11/20/20 KATU Family Matters AMNW segment with Dr. Rachel Sanborn from Providence Cancer Institute in Portland, Oregon,